Arrowhead Pharmaceuticals
ARWR
#2278
Rank
S$10.51 B
Marketcap
S$74.46
Share price
1.22%
Change (1 day)
43.59%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): S-$2.37

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$4.26. In 2022 the company made an earnings per share (EPS) of S-$1.87 an increase over its 2021 EPS that were of S-$2.25.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$2.3726.89%
2022S-$1.87-17.05%
2021S-$2.2574.26%
2020S-$1.29-283.64%
2019S$0.70-257.14%
2018S-$0.45-27.08%
2017S-$0.61-59.32%
2016S-$1.51-21.85%
2015S-$1.939.42%
2014S-$1.772.87%
2013S-$1.72-31.56%
2012S-$2.51300%
2011S-$0.63-45.56%
2010S-$1.15-66.67%
2009S-$3.46-63.51%
2008S-$9.47-12.94%
2007S-$10.8844.07%
2006S-$7.5577.35%
2005S-$4.2610.66%
2004S-$3.85-54.25%
2003S-$8.41-80.51%
2002S-$43.173.87%
2001S-$41.56116.17%
2000S-$19.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.56-300.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
S-$10.23 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$12.82-400.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$25.36-694.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
S-$2.34-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA